This independent RP-HPLC lab test confirms Tirzepatide 60mg from Hydro Research Peptides at 99.975% purity. The analysis was conducted by Chromate on July 22, 2025. The tested sample contained 64.68mg of the stated peptide compound, representing a +7.8% overage.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. Studies indicate potential applications in type 2 diabetes management and obesity research. A purity level of 99.975% indicates exceptional high-grade synthesis with minimal contamination.
The full certificate of analysis is available for verification at chromate.org/verify/ using the access code HYDROA1SHM56.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.